These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7492066)

  • 1. Second primary malignancies in the head and neck cancer patient.
    Sturgis EM; Miller RH
    Ann Otol Rhinol Laryngol; 1995 Dec; 104(12):946-54. PubMed ID: 7492066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of thorax imaging in staging head and neck squamous cell carcinoma.
    Ong TK; Kerawala CJ; Martin IC; Stafford FW
    J Craniomaxillofac Surg; 1999 Dec; 27(6):339-44. PubMed ID: 10870751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
    Tsou YA; Hua CH; Tseng HC; Lin MH; Tsai MH
    Acta Otolaryngol; 2007 Jun; 127(6):651-7. PubMed ID: 17503236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six primary squamous cell carcinomas of the head and neck.
    Hao SP
    Auris Nasus Larynx; 1998 Jan; 25(1):101-4. PubMed ID: 9512801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.
    Matsubara T; Yamada K; Nakagawa A
    J Clin Oncol; 2003 Dec; 21(23):4336-41. PubMed ID: 14645422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esosphageal cancer or head and neck cancer.
    Hori K; Okada H; Kawahara Y; Takenaka R; Shimizu S; Ohno Y; Onoda T; Sirakawa Y; Naomoto Y; Yamamoto K
    Am J Gastroenterol; 2011 May; 106(5):858-66. PubMed ID: 21468010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
    Jégu J; Binder-Foucard F; Borel C; Velten M
    Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of risk factors for the development of a second primary malignancy in the head and neck.
    Bhattacharyya N
    Ear Nose Throat J; 2006 Feb; 85(2):121-5. PubMed ID: 16579204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous or metachronous lymphoma and metastatic cutaneous squamous cell carcinoma in the head and neck region: a diagnostic and management dilemma.
    Kader I; Leavers B; Shashinder S; Wylie B; Chi KK; Sundaresan P
    J Laryngol Otol; 2016 Jul; 130 Suppl 4():S45-9. PubMed ID: 27488337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of PET/CT for detecting a second primary cancer after treatment for squamous cell carcinoma of the head and neck.
    Bold B; Piao Y; Murata Y; Kishino M; Shibuya H
    Clin Nucl Med; 2008 Dec; 33(12):831-3. PubMed ID: 19033780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes for second primary head and neck cancer: a matched analysis.
    Bhattacharyya N; Nayak VK
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):63-8. PubMed ID: 15632911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in second primary malignancies of patients with head and neck cancer.
    Di Martino E; Sellhaus B; Hausmann R; Minkenberg R; Lohmann M; Esthofen MW
    J Laryngol Otol; 2002 Oct; 116(10):831-8. PubMed ID: 12437840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
    Chowdhry AK; McHugh C; Fung C; Dhakal S; Constine LS; Milano MT
    Cancer; 2015 May; 121(9):1436-45. PubMed ID: 25572913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.
    Cooper JS; Pajak TF; Rubin P; Tupchong L; Brady LW; Leibel SA; Laramore GE; Marcial VA; Davis LW; Cox JD
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):449-56. PubMed ID: 2674073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivorship--competing mortalities, morbidities, and second malignancies.
    Montero-Miranda PH; Ganly I
    Otolaryngol Clin North Am; 2013 Aug; 46(4):681-710. PubMed ID: 23910478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary and secondary pulmonary tumors associated with head and neck carcinoma].
    Morone G; Meriggi F; Forni E
    Ann Ital Chir; 1997; 68(4):511-6. PubMed ID: 9494182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for multiple malignancies in the head and neck.
    Deganello A; Gitti G; Mannelli G; Meccariello G; Gallo O
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):105-11. PubMed ID: 23535708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.